Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) announced that partner Hansoh Pharmaceutical Group Company Limited reported positive results from a Phase 3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA